[HTML][HTML] Cannabinoids as multifaceted compounds

D Persia, F Mangiavacchi, MC Marcotullio, O Rosati - Phytochemistry, 2023 - Elsevier
Since ancient times, Cannabis and its preparations have found various applications such as
for medical, recreational and industrial purposes. Subsequently the 1930s, legislation in …

Cannabinoids: Potential for Modulation and Enhancement When Combined with Vitamin B12 in Case of Neurodegenerative Disorders

AA Kaszyńska - Pharmaceuticals, 2024 - mdpi.com
The enduring relationship between humanity and the cannabis plant has witnessed
significant transformations, particularly with the widespread legalization of medical …

Decoding the therapeutic potential of cannabis and cannabinoids in neurological disorders

MB Kale, MD Umare, NL Wankhede… - Current …, 2024 - benthamdirect.com
For millennia, Cannabis sativa has served diverse roles, from medicinal applications to
recreational use. Despite its extensive historical use, only a fraction of its components have …

[HTML][HTML] Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection

MJ Jembrek - Antioxidants, 2024 - mdpi.com
Oxidative stress, characterized by increased production of reactive oxygen species (ROS)
and disturbed redox homeostasis, is one of the key mechanisms underlying synaptic loss …

Trifluoro-Icaritin Ameliorates Neuroinflammation Against Complete Freund's Adjuvant-Induced Microglial Activation by Improving CB2 Receptor-Mediated IL-10/β …

G Liu, D Jia, W Li, Z Huang, R Shan… - Journal of Neuroimmune …, 2024 - Springer
The underlying pathogenesis of chronic inflammatory pain is greatly complex, but the
relevant therapies are still unavailable. Development of effective candidates for chronic …

Increasing CB2 Receptor Activity after Early Life Stress Prevents Depressive Behavior in Female Rats

SL Andersen - Biomolecules, 2024 - mdpi.com
Early adversity, the loss of the inhibitory GABAergic interneuron parvalbumin, and elevated
neuroinflammation are associated with depression. Individuals with a maltreatment history …

[HTML][HTML] The Endocannabinoid System of the Nervous and Gastrointestinal Systems Changes after a Subnoxious Cisplatin Dose in Male Rats

Y López-Tofiño, MA Hopkins, A Bagues, L Boullon… - Pharmaceuticals, 2024 - mdpi.com
Background/Objectives: Cisplatin, a common chemotherapy agent, is well known to cause
severe side effects in the gastrointestinal and nervous systems due to its toxic and pro …

[PDF][PDF] Prevalence and incidence of Huntington's disease comment on Medina et al (2022)

M Strong, O Quarrell - Movement Disorders, 2023 - eprints.whiterose.ac.uk
Unfortunately, the software that the authors used, Comprehensive Meta-Analysis Software,
rather confusingly reports a “Q* statistic”(along with an I2 value calculated from this value of …

Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders

G Wilson, L Yang, X Su, S Ding, L Li, Y Yang… - Pharmacological …, 2023 - Springer
Cannabinoid receptors, endogenous cannabinoids (endocannabinoids), and the enzymes
involved in the biosynthesis and degradation of the endocannabinoids make up the …

A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand binding assay.

L Borrega-Roman, BL Hoare, M Kosar, RC Sarott… - bioRxiv, 2024 - biorxiv.org
INTRODUCTION: The kinetics of ligand binding to G protein-coupled receptors (GPCRs) is
an important determining factor in the preclinical evaluation of a molecule. Therefore, efforts …